Walvax unit receives China regulatory approval for COVID-19 mRNA vaccine
Walvax Biotechnology Co Ltd’s unit received China regulatory approval for a COVID-19 mRNA vaccine. The company is associated with SZSE:300142.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.